Anaplastic lymphoma kinase (ALK) gene alteration in gastric signet ring cell carcinoma

Siegel R. , Ma J. , Zou Z. , and Jemal A. , Cancer statistics, 2014. CA Cancer J Clin 64 (2014) 9-29.

Karimi P. , Islami F. , Anandasabapathy S. , Freedman N.D. , and Kamangar F. , Gastric cancer: Descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 23 (2014) 700-13.

Piessen G. , Messager M. , Le Malicot K. , Robb W.B. , Di Fiore F. , Guilbert M. , Moreau M. , Christophe V. , Adenis A. , and Mariette C. , Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002. BMC Cancer 13 (2013) 281.

Piessen G. , Messager M. , Leteurtre E. , Jean-Pierre T. , and Mariette C. , Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation. Annals of Surgery 250 (2009) 878-887.

Morris S.W. , Kirstein M.N. , Valentine M.B. , Dittmer K.G. , Shapiro D.N. , Saltman D.L. , and Look A.T. , Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263 (1994) 1281-4.

Soda M. , Choi Y.L. , Enomoto M. , Takada S. , Yamashita Y. , Ishikawa S. , Fujiwara S. , Watanabe H. , Kurashina K. , Hatanaka H. , Bando M. , Ohno S. , Ishikawa Y. , Aburatani H. , Niki T. , Sohara Y. , Sugiyama Y. , and Mano H. , Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448 (2007) 561-6.

Shaw A.T. , Solomon B. , and Kenudson M.M. , Crizotinib and testing for ALK. J Natl Compr Canc Netw 9 (2011) 1335-41.

Kwak E.L. , Bang Y.J. , Camidge D.R. , Shaw A.T. , Solomon B. , Maki R.G. , Ou S.H. , Dezube B.J. , Janne P.A. , Costa D.B. , Varella-Garcia M. , Kim W.H. , Lynch T.J. , Fidias P. , Stubbs H. , Engelman J.A. , Sequist L.V. , Tan W. , Gandhi L. , Mino-Kenudson M. , Wei G.C. , Shreeve S.M. , Ratain M.J. , Settleman J. , Christensen J.G. , Haber D.A. , Wilner K. , Salgia R. , Shapiro G.I. , Clark J.W. , and Iafrate A.J. , Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363 (2010) 1693-703.

Rodig S.J. , Mino-Kenudson M. , Dacic S. , Yeap B.Y. , Shaw A. , Barletta J.A. , Stubbs H. , Law K. , Lindeman N. , Mark E. , Janne P.A. , Lynch T. , Johnson B.E. , Iafrate A.J. , and Chirieac L.R. , Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res 15 (2009) 5216-23.

Foltyn W , Zaj?cki W , Marek B , Kajdaniuk D , Siemińska L , Zemczak A , Kos-Kudƚa B , The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours. Endokrynol Pol 63 (2012) 5.

Ying J. , Guo L. , Qiu T. , Shan L. , Ling Y. , Liu X. , and Lu N. , Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma. Ann Oncol 24 (2013) 2589-93.

Fu S. , Wang H.Y. , Wang F. , Huang M.Y. , Deng L. , Zhang X. , Ye Z.L. , and Shao J.Y. , Clinicopathologic characteristics and therapeutic responses of Chinese patients with non-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement. Chin J Cancer 34 (2015) 35.

Chan B.A. , and Hughes B.G. , Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future. Transl Lung Cancer Res 4 (2014) 36-54.

Schneeweiss A. , Ruckhaberle E. , and Huober J. , Chemotherapy for Metastatic Breast Cancer - An Anachronism in the Era of Personalised and Targeted Oncological Therapy? Geburtshilfe Frauenheilkd 75 (2015) 574-583.

Oholendt A.L. , and Zadlo J.L. , Ramucirumab: A New Therapy for Advanced Gastric Cancer. J Adv Pract Oncol 6 (2015) 71-5.

Bang Y.J. , Van Cutsem E. , Feyereislova A. , Chung H.C. , Shen L. , Sawaki A. , Lordick F. , Ohtsu A. , Omuro Y. , Satoh T. , Aprile G. , Kulikov E. , Hill J. , Lehle M. , Ruschoff J. , and Kang Y.K. , Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet 376 (2010) 687-97.

Liao B.C. , Lin C.C. , Shih J.Y. , and Yang J.C. , Treating patients with ALK-positive non-small cell lung cancer: Latest evidence and management strategy. Ther Adv Med Oncol 7 (2015) 274-90.

Panagopoulos I. , Nilsson T. , Domanski H.A. , Isaksson M. , Lindblom P. , Mertens F. , and Mandahl N. , Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. Int J Cancer 118 (2006) 1181-6.

Debelenko L.V. , Raimondi S.C. , Daw N. , Shivakumar B.R. , Huang D. , Nelson M. , and Bridge J.A. , Renal cell carcinoma with novel VCL-ALK fusion: New representative of ALK-associated tumor spectrum. Mod Pathol 24 (2011) 430-42.

Lin E. , Li L. , Guan Y. , Soriano R. , Rivers C.S. , Mohan S. , Pandita A. , Tang J. , and Modrusan Z. , Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol Cancer Res 7 (2009) 1466-76.

Butrynski J.E. , D'Adamo D.R. , Hornick J.L. , Dal Cin P. , Antonescu C.R. , Jhanwar S.C. , Ladanyi M. , Capelletti M. , Rodig S.J. , Ramaiya N. , Kwak E.L. , Clark J.W. , Wilner K.D. , Christensen J.G. , Janne P.A. , Maki R.G. , Demetri G.D. , and Shapiro G.I. , Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 363 (2010) 1727-33.

Mano H. , ALKoma: a cancer subtype with a shared target. Cancer Discov 2 (2012) 495-502.

Fukuyoshi Y , Inoue H , Kita Y , Utsunomiya T , Ishida T , and Mori M , EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers. Br J Cancer 98 (2008) 1536-1539.

Chon H.J. , Kim H.R. , Shin E. , Kim C. , Heo S.J. , Lee C.K. , Park J.K. , Noh S.H. , Chung H.C. , and Rha S.Y. , The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer. Ann Surg Oncol 22 (2015) 3938-45.

Alese O.B. , El-Rayes B.F. , Sica G. , Zhang G. , Alexis D. , La Rosa F.G. , Varella-Garcia M. , Chen Z. , Rossi M.R. , Adsay N.V. , Khuri F.R. , and Owonikoko T.K. , Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract. Ther Adv Med Oncol 7 (2015) 56-62.

Mino-Kenudson M. , Chirieac L.R. , Law K. , Hornick J.L. , Lindeman N. , Mark E.J. , Cohen D.W. , Johnson B.E. , Janne P.A. , Iafrate A.J. , and Rodig S.J. , A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clin Cancer Res 16 (2010) 1561-71.